title: Response to: 'Which B-cell subset should we target in lupus?' by Ferraccioli and Houssiau.
authors.affiliation: Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds, UK.
authors.forename: Gururaj
authors.initials: G
authors.lastname: Arumugakani
authors.forename: Edward M
authors.initials: EM
authors.lastname: Vital
authors.forename: Md Yuzaiful
authors.initials: MY
authors.lastname: Md Yusof
authors.forename: Dennis G
authors.initials: DG
authors.lastname: McGonagle
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
mesh_terms: D000818:Animals; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D006801:Humans; D008181:Lupus Nephritis / Q000276:immunology*; D008212:Lymphocyte Depletion / Q000379:methods*
keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics